(Q33369267)

English

Phase III study of second-line chemotherapy for advanced non-small-cell lung cancer with weekly compared with 3-weekly docetaxel

scientific article

Statements

Phase III study of second-line chemotherapy for advanced non-small-cell lung cancer with weekly compared with 3-weekly docetaxel (English)
Thomas Blankenburg
Christine Lautenschlaeger
Ernst-Wilhelm Schmidt
Ina Dittrich
Hans Schweisfurth
Aruna Raghavachar
Angelika Reissig
Monika Serke
1 November 2005
8389-8395

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit